Merck Cash on Hand 2010-2024 | MKKGY
Merck cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- Merck cash on hand for the quarter ending June 30, 2024 was $3.031B, a 44.27% increase year-over-year.
- Merck cash on hand for 2023 was $2.685B, a 17.18% increase from 2022.
- Merck cash on hand for 2022 was $2.292B, a 6.56% decline from 2021.
- Merck cash on hand for 2021 was $2.453B, a 45.07% increase from 2020.
Merck Annual Cash on Hand
(Millions of US $) |
| 2023 |
$2,685 |
| 2022 |
$2,292 |
| 2021 |
$2,453 |
| 2020 |
$1,691 |
| 2019 |
$939 |
| 2018 |
$2,591 |
| 2017 |
$767 |
| 2016 |
$1,200 |
| 2015 |
$1,175 |
| 2014 |
$6,750 |
| 2013 |
$4,505 |
| 2012 |
$3,251 |
| 2011 |
$2,862 |
| 2010 |
$ |
| 2009 |
$ |
Merck Quarterly Cash on Hand
(Millions of US $) |
| 2024-06-30 |
$3,031 |
| 2024-03-31 |
$2,697 |
| 2023-12-31 |
$2,685 |
| 2023-09-30 |
$2,811 |
| 2023-06-30 |
$2,101 |
| 2023-03-31 |
$1,847 |
| 2022-12-31 |
$2,292 |
| 2022-09-30 |
$1,965 |
| 2022-06-30 |
$1,823 |
| 2022-03-31 |
$1,622 |
| 2021-12-31 |
$2,453 |
| 2021-09-30 |
$1,963 |
| 2021-06-30 |
$2,253 |
| 2021-03-31 |
$2,770 |
| 2020-12-31 |
$1,691 |
| 2020-09-30 |
$1,909 |
| 2020-06-30 |
$1,700 |
| 2020-03-31 |
$1,777 |
| 2019-12-31 |
$939 |
| 2019-09-30 |
$5,989 |
| 2019-06-30 |
$4,051 |
| 2019-03-31 |
$2,730 |
| 2018-12-31 |
$2,591 |
| 2018-09-30 |
$1,039 |
| 2018-06-30 |
$869 |
| 2018-03-31 |
$1,007 |
| 2017-12-31 |
$767 |
| 2017-09-30 |
$1,114 |
| 2017-06-30 |
$1,245 |
| 2017-03-31 |
$1,220 |
| 2016-12-31 |
$1,200 |
| 2016-09-30 |
$1,076 |
| 2016-06-30 |
$934 |
| 2016-03-31 |
$1,089 |
| 2015-12-31 |
$1,175 |
| 2015-09-30 |
$12,938 |
| 2015-06-30 |
$9,605 |
| 2015-03-31 |
$8,849 |
| 2014-12-31 |
$6,750 |
| 2014-09-30 |
$3,523 |
| 2014-06-30 |
$2,473 |
| 2014-03-31 |
$5,121 |
| 2013-12-31 |
$4,505 |
| 2013-09-30 |
$4,381 |
| 2013-06-30 |
$4,344 |
| 2013-03-31 |
$3,832 |
| 2012-12-31 |
$3,251 |
| 2012-09-30 |
$3,663 |
| 2012-06-30 |
$2,859 |
| 2012-03-31 |
|
| 2011-12-31 |
$2,862 |
| 2011-09-30 |
|
| 2011-06-30 |
$2,471 |
| 2011-03-31 |
|
| 2010-12-31 |
|
| 2010-09-30 |
$1,913 |
| 2010-06-30 |
|
| 2010-03-31 |
|
| 2009-12-31 |
|
| 2009-09-30 |
|
| 2009-06-30 |
|
| 2009-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.306B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
